Navidea Biopharmaceuticals Inc Ret. on assets
What is the Ret. on assets of Navidea Biopharmaceuticals Inc?
The Ret. on assets of Navidea Biopharmaceuticals Inc is -87.38%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc
What does Navidea Biopharmaceuticals Inc do?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Companies with ret. on assets similar to Navidea Biopharmaceuticals Inc
- Pure Minerals has Ret. on assets of -87.74%
- CMC Metals has Ret. on assets of -87.65%
- CMC Metals has Ret. on assets of -87.65%
- Wide Open Agriculture has Ret. on assets of -87.65%
- Adherium has Ret. on assets of -87.59%
- Tesoro Minerals has Ret. on assets of -87.39%
- Navidea Biopharmaceuticals Inc has Ret. on assets of -87.38%
- Unit Corp has Ret. on assets of -87.35%
- Canxgold Mining Corp has Ret. on assets of -87.35%
- Ozz Resources has Ret. on assets of -87.34%
- Covia has Ret. on assets of -87.33%
- Mexus Gold US has Ret. on assets of -87.29%
- Omai Gold Mines Corp has Ret. on assets of -87.18%